<?xml version="1.0" encoding="UTF-8"?>
<p id="p0355">Another clinical trial started on May 8, 2020 exploiting a medical spray containing curcumin (20 mg/ml), artemisinin (6 mg/ml), frankincense (15 mg/ml) -and vitamin C (60 mg/ml) in micellar formulation against SARS-CoV2 infections (
 <xref rid="appsec1" ref-type="sec">Table S1</xref>).
</p>
